Kure Advisory’s Medtronic MDT Stock Holding History

Kure Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,353	Closed	-$204K	–	66
2026 Q1	$204K	Buy	2,353 +13	+0.6%	+$1.25K	0.11%	54
2025 Q4	$225K	Buy	+2,340	New	+$227K	0.13%	51
2025 Q2	–	Sell	-5,944	Closed	-$534K	–	47
2025 Q1	$534K	Buy	+5,944	New	+$532K	0.4%	24
2024 Q3	$839K	Sell	9,322 -35	-0.4%	-$2.94K	0.75%	18
2024 Q2	$736K	Buy	9,357 +32	+0.3%	+$2.62K	0.6%	21
2024 Q1	$813K	Sell	9,325 -908	-9%	-$77.5K	0.69%	18
2023 Q4	$843K	Sell	10,233 -193	-2%	-$14.7K	0.44%	36
2023 Q3	$817K	Buy	+10,426	New	+$873K	0.46%	38

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kure Advisory's MDT Position: Q2 2026 in Review

Kure Advisory sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,353 shares — an estimated $204K sold.

Kure Advisory first reported a position in MDT in Q3 2023 and held it in 8 quarters. The position peaked at $843K in Q4 2023. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Kure Advisory reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
Kure Advisory sold 2,353 Medtronic shares in Q2 2026, an estimated $204K.
Kure Advisory first reported a position in Medtronic in Q3 2023 and held it in 8 quarters.
Kure Advisory's Medtronic position peaked at $843K in Q4 2023.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kure Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.